Cargando…
Acid sphingomyelinase inhibition improves motor behavioral deficits and neuronal loss in an amyotrophic lateral sclerosis mouse model
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease characterized by the degeneration of motor neurons in the spinal cord. Main symptoms are manifested as weakness, muscle loss, and muscle atrophy. Some studies have reported that alterations in sphingolipid metabolism may b...
Autores principales: | Choi, Byung Jo, Park, Kang Ho, Park, Min Hee, Huang, Eric Jinsheng, Kim, Seung Hyun, Bae, Jae-sung, Jin, Hee Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813424/ https://www.ncbi.nlm.nih.gov/pubmed/36229415 http://dx.doi.org/10.5483/BMBRep.2022.55.12.142 |
Ejemplares similares
-
Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis
por: Yousefian-Jazi, Ali, et al.
Publicado: (2020) -
Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis
por: Nijssen, Jik, et al.
Publicado: (2017) -
Motor neuron replacement therapy for amyotrophic lateral sclerosis
por: Liu, Bochao, et al.
Publicado: (2022) -
Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis
por: Allen, Scott P, et al.
Publicado: (2019) -
Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis
por: Christidi, Foteini, et al.
Publicado: (2018)